Connect with us

Harris | Bricken

Happy Thanksgiving from the Canna Law Blog

Published

on


Canna Law Blog

The Canna Law Blog is a forum for discussing the practical aspects of cannabis law and its impacts on the cannabis industry. We provide insight into how cannabis businesspeople can use the law to their advantage and in plain language we tell you what works and what does not. We aim to help you strategize how to wield the law as both a shield and a sword.

Harris Bricken Blog Read more posts

Read full article on HarrisBricken



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Harris | Bricken

What Every CAURD Applicant Needs to Know

Published

on

By


Register Here

Date: December 7th, 2022

Time: 2 – 3pm EST

New York recently released its adult-use cannabis retail dispensary guidelines and there is a lot to unpack. We will likely see additional changes to New York’s rules and regulations, but the released guidelines provide a robust initial framework for applicants (past and future) to follow.

Join Harris Bricken’s lead New York cannabis attorneys, Simon Malinowski and Matthew Schwartz as they analyze the recently released regulations.

Simon and Matt will cover operating requirements, employee training, and marketing rules, among many other topics covered in New York’s retail dispensary guidelines.

Check out some of our past Canna Law Blog posts on New York’s cannabis regulation updates:

BREAKING: NY Federal Judge Blocks CAURD Licensing in Five Regions New York’s Cannabis Retail Dispensary Regulations Are Here! New York’s Cannabis Retail Dispensary Regulations, Part 1: Dispensary Operations

Read full article on HarrisBricken



Source link

Continue Reading

Harris | Bricken

Will the Senate Ever Do Anything with the SAFE Banking Act?

Published

on

By


As we’ve written about over the past several years, there have been consistent rallying cries for common-sense banking reform for the cannabis industry.

The SAFE Banking Act, which would allow federally regulated financial institutions to work with state-legal cannabis businesses, has been passed by the U.S. House of Representatives a whopping seven times. However, the Senate has yet to take up the SAFE Banking Act, ever – despite the fact that it’s sponsored by Senator Jeff Merkley and has 42 co-sponsors.

The ICBA letter

The Independent Community Bankers Association (“ICBA”) is now urging Senate Majority Leader Chuck Schumer (D-NY) and Minority Leader Mitch McConnell (R-KY) to do something with the bill by the end of the year, in this lame duck session of Congress. The letter penned by the ICBA and 44 state banking associations states:

This legislation enjoys strong, bipartisan support, would resolve a conflict between state and federal law, and addresses a critical public safety concern. We urge its enactment without further delay … The Act would create a safe harbor from federal sanctions for financial institutions that serve cannabis-related businesses (CRBs), as well as the numerous ancillary businesses that serve them, in states and other jurisdictions where

Read full article on HarrisBricken



Source link

Continue Reading

Harris | Bricken

Washington Cannabis Update: Non-CBD Cannabinoid Additives

Published

on

By


The Washington State Liquor and Cannabis Board (“LCB”) has clarified what cannabinoid additives are allowed in Cannabis products in WA. The LCB recently published a notice that it had adopted interpretive statement IS22-01, “Use of Additives in Authorized Cannabis Products”. The adopted policy statement clarifies that non-cannabidiol (“non-CBD”) cannabinoids may be added to cannabis products in WA if they have been produced by or purchased from an LCB-licensed processor or processor within the I-502 (adult-use statute) system.

Cannabinoids

The cannabis sativa plant produces over 100 cannabinoids, not all of which have psychoactive or intoxicating effects. The two most common cannabinoids are delta-9-tetrahydrocannabinol (“THC”) and cannabidiol (“CBD”). THC is the cannabinoid that has psychoactive effects resulting in users getting “high”, while CBD is not considered psychoactive and is used for a variety of purposes including as an FDA approved treatment for epilepsy (Epidiolex).

The Revised Code of Washington (“RCW”) chapter 69.50.326 already allows for the addition of CBD to cannabis products, but in 2020 the LCB became aware of other cannabinoids being added to cannabis products and has sought to provide guidance on the matter ever since.

Legalization of recreational cannabis in the many U.S. states has led to the development

Read full article on HarrisBricken



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media